A Series B fintech founder books Forbes on a regulatory thesis
“Coverage that signaled regulatory sophistication, not generic startup hype”
A fintech founder mid-Series B needed coverage that signaled regulatory sophistication, not generic startup hype.
Where the engagement started.
The founder had been publicly opposing a pending regulatory shift for two years on social channels and at industry conferences. Investors were pushing for a tier-1 article that would consolidate the thesis in a single high-authority venue.
How we framed the story.
We developed a thesis-led story around the regulatory shift, with the founder as the named source and primary commentator. The article would not be a profile of the company. It would be a category piece in which the founder happened to be the most-quoted operator.
What we actually did.
We coordinated with a Forbes contributor whose recent work touched the same regulatory territory. Two rounds of edits, no photography needed for the format.
The piece ran in Forbes, quoted the founder five times, and was picked up in two follow-on trade outlets within ten days.
The piece ran in Forbes, quoted the founder five times, and was picked up in two follow-on trade outlets within ten days. Investor inbound and a strategic-partner conversation both traced to the placement. The Series B closed sixty days later, oversubscribed.
- 0 daysTime to publication
- 0Founder quotes in article
- 0Follow-on trade pickups within 10 days
The article became the artifact every investor and partner was sent before a meeting. It saved us forty hours of explaining what we do.
More from tech founders and adjacent verticals.
Bring us your next milestone. We will name the outlets, the embargoes, and the day it should run.
Thirty-minute editorial brief, no obligation. We tell you which publications are realistic for your story before you commit.